ÂÜÀòÂÒÂ×

Joerg Koglin is a Senior Vice President at Merck, leading global clinical development for various therapeutic areas. Prior to this, Joerg held various roles in cardiovascular clinical research at companies such as Boston Scientific. Joerg also served as an Assistant Professor at LMU, specializing in Cardiology and Cardiovascular Biology. Koglin holds a Doctor of Medicine and a Doctor of Philosophy in Medicine, as well as postdoctoral and executive education degrees.